Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Research, development and commercialization of our proprietary enzymes and devices1.02B100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States690.46M68.00%
Switzerland212.39M20.92%
Belgium84.01M8.27%
Japan18.94M1.87%
All Other Foreign9.53M0.94%